Log In
person
OPKO Health Inc
OPK
summarize
6 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Intellectual Property |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
180.66M | 20.92% |
| Products (Pharmaceuticals) |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
167.56M | 19.40% |
| Services (Diagnostic) |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
315.56M | 36.54% |
| Services (Diagnostic) |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
100.17M | 11.60% |
| Services (Diagnostic) |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Government Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
82.5M | 9.55% |
| Services (Diagnostic) |
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
17.04M | 1.97% |
| keyboard_arrow_down |
Intellectual Property
Pharmaceutical Patent Licensing
|
180.66M | 20.92% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Products (Pharmaceuticals)
Branded Pharmaceuticals (outsourced)
|
167.56M | 19.40% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Services (Diagnostic)
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
|
315.56M | 36.54% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||
| keyboard_arrow_down |
Services (Diagnostic)
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
|
100.17M | 11.60% |
| keyboard_arrow_right |
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
|
||
| keyboard_arrow_down |
Services (Diagnostic)
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Government Insurance
|
82.5M | 9.55% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
||
| keyboard_arrow_down |
Services (Diagnostic)
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
|
17.04M | 1.97% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||